Servier gets first FDA nod for targeted therapy in rare type of blood cancer

The latest stories trending on MedCity News.

Editor's Pick

Top Story Servier Gets First FDA Nod for Targeted Therapy in Rare Type of Blood Cancer Servier drug Tibsovo is now approved for treating advanced cases of myelodysplastic syndrome that have an IDH1 mutation. It's the first approval of a targeted therapy for this type of cancer. Sponsored Content Execs Share Progress on Digital Health for Pharma, Hospitals, and Behavioral Health Care Coordination Presented by MedCity News Heard at HLH series from Las Vegas.  Executives from BrightInsight, Iodine Software, Intelligent Medical Objects, Altera Digital Health and Trayt Health shared new developments across their businesses and perspectives on value-based care at the HLTH 2023 event earlier this month. https://medcitynews.com/2023/10/heard-at-hlth-2023-execs-share-progress-on-digital-health-for-pharma-hospitals-and-behavioral-health-care-coordination/ Learn more here.

Featured News

Switzerland Global Enterprise Seeks to Strengthen Ties with Healthcare Companies and Texas In the runup to the MedCity INVEST Digital Health conference, Christoph Besmer, a trade commissioner and head of investment promotion with Swiss Business Hub USA, talked about the "X Marks the Spot" campaign and how Switzerland Global Enterprise hopes to strengthen ties with U.S. health tech companies.  Pair Team Secures $9M To Improve Health Access for Medicaid Patients Pair Team's $9 million Series A funding round was led by Next Ventures and included participation from PTX Capital, Create Health Ventures, OCA Ventures, CHCF Innovation Fund, Kapor Capital and other investors. In total, Pair Team has raised about $20 million. The Data Tsunami is Here—And it's Time for "Smart" Views of Clinical Data The healthcare industry must prioritize the development and implementation of universal tools that can efficiently navigate, interpret, and derive value from the growing wealth of health data. J&J's Robotic Bronchoscopy System Could Help Physicians Detect Cancer Sooner, Research Finds Johnson & Johnson released research this month showing that its system for robotic-assisted bronchoscopy helped physicians achieve an over 15% improvement in overall diagnostic yield compared to traditional bronchoscopy. This could mean that fewer patients will have to "wait and see" while their cancer potentially gets worse. HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.

Resources

Heard at HLTH 2023: Execs Share Progress on Digital Health for Pharma, Hospitals, and Behavioral Health Care Coordination In the second part of the Heard at HLTH series, executives from BrightInsight, Iodine Software, Intelligent Medical Objects, Carrum Health, Clarify Health and Trayt Health shared new developments across their businesses and perspectives on value-based care at the HLTH 2023 event. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe